YD Bio Return on Equity (ROE) Growth & History (YDES)
YD Bio's return on equity was −445.10% for fiscal 2025.
View full YD Bio company overviewYD Bio annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −445.10% | −402.41 pp |
| 2024 | 2024-12-31 | −42.69% | — |
YD Bio return on equity trends
Between the periods ended 2024-12-31 and 2025-12-31, YD Bio's return on equity decreased from −42.69% to −445.10%, a change of −402.41 percentage points.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review YD Bio source filings ↗